Nordic Nanovector is committed to developing and delivering innovative therapies to patients to address major unmet medical needs. The Company aspires to become a leader in the development of CD37-targeted therapies for hematological cancers and immune diseases.

Biotechnology

Nordic Nanovector

Ludvik Sandnes

Stein Rune Kjelby

margrethe Sørgaard

Lars Nieba

Jostein Dahle

The Scientific Advisory Team at Nordic Nanovector is composed of expert advisors who provide strategic guidance and insights on the development of CD37-targeted therapies. They assess scientific research, evaluate clinical data, and offer recommendations to enhance therapeutic efficacy, ensuring that the company's innovations effectively address unmet medical needs in hematological cancers and immune diseases.

Scientific Advisory Team

About

Team members

Other teams at Nordic Nanovector

Leadership Team